Qiagen, Bio-Rad, Millipore, Luminex, Sequenom, Applied Microarrays, GE Healthcare, NorDiag, Cepheid, Sigma-Aldrich | GenomeWeb
Qiagen Posts 18 Percent Q1 Revenue Growth
 
Qiagen this week said first-quarter revenue rose 18 percent as R&D spending increased 13 percent and net income was up 13 percent.
 
Total revenue for the three months ended March 31, 2007, rose to $127.9 million from $108.7 million year over year.
 
Qiagen said that the strong sales were fuelled in part by an 11 percent increase in organic growth and a 2 percent contribution from acquisitions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.